ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ENVB Enveric Biosciences Inc

0.83
0.00 (0.00%)
시간외 단일가
최종 업데이트: 18:22:39
15분 지연
기업명 주식 심볼 시장 주식 타입
Enveric Biosciences Inc ENVB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.83 18:22:39
개장가 저가 고가 종가 전일 종가
0.83
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/05/202421:00EDGAR2Form 8-K - Current report
18/05/202406:25EDGAR2Form 8-K - Current report
15/05/202419:00BWEnveric Biosciences Reports First Quarter 2024 Financial and..
14/05/202421:00BWEnveric Biosciences Signs $66.5 Million Non-Binding Term..
08/05/202420:00BWEnveric Biosciences Announces Signing of Non-Binding Term..
26/03/202420:00BWEnveric Biosciences Reports Financial Results and Provides..
19/03/202420:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
12/03/202420:00BWEnveric Biosciences Announces New Patent Issuances..
12/03/202401:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/03/202421:00EDGAR2Form 8-K - Current report
29/02/202421:00EDGAR2Form 8-K - Current report
29/02/202421:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
27/02/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202422:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
21/02/202422:05EDGAR2Form 8-K - Current report
21/02/202422:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
15/02/202405:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/02/202422:05EDGAR2Form 8-K - Current report
07/02/202400:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202407:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/01/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
12/01/202406:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09/01/202406:42EDGAR2Form 8-K - Current report
03/01/202422:05EDGAR2Form 8-K - Current report
30/12/202306:43EDGAR2Form 8-K - Current report
29/12/202322:52BWEnveric Biosciences Announces Exercise of Warrants and..
28/12/202322:05EDGAR2Form 8-K - Current report
28/12/202322:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
27/12/202322:05EDGAR2Form 8-K - Current report
27/12/202322:00BWEnveric Biosciences Reports Year End Progress for..
20/12/202322:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
07/12/202306:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:00BWEnveric Biosciences Selects Development Candidates from..
02/12/202306:31EDGAR2Form S-1/A - General form for registration of securities..
29/11/202322:18EDGAR2Form 8-K - Current report
29/11/202322:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
27/11/202322:00BWEnveric Biosciences Announces Manuscript Describing the..
24/11/202322:00BWEnveric Biosciences Announces Presentation of Two Posters at..
23/11/202306:30EDGAR2Form 8-K - Current report
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:01BWEnveric Biosciences Reports Third Quarter 2023 Corporate and..
06/11/202322:05EDGAR2Form 8-K - Current report
03/11/202306:29EDGAR2Form 8-K - Current report
31/10/202321:05EDGAR2Form 8-K - Current report
31/10/202321:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..

최근 히스토리

Delayed Upgrade Clock